Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans

Hepatology

Volumn 51, Issue 3, 2010, Pages 974-985

  Moreno, Montserrat ^a   Chaves, Javier F ^a   Sancho Bru, Pau ^a   Ramalho, Fernando ^b   Ramalho, Leandra N ^a   Mansego, Maria L ^a   Ivorra, Carmen ^a   Dominguez, Marlene ^a   Conde, Laura ^c   Milĺan, Cristina ^a   Marí, Montserrat ^a   Colmenero, Jordi ^a   Lozano, Juan J ^a   Jares, Pedro ^c   Vidal, Josep ^c   Forns, Xavier ^a   Arroyo, Vicente ^a   Caballerýía, Juan ^a   Giǹes, Pere ^a   Bataller, Raḿon ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; GHRELIN; RECOMBINANT GHRELIN; RECOMBINANT HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BIOACCUMULATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; DRUG EFFECT; FIBROGENESIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS C; HUMAN; IN VITRO STUDY; LIVER; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER INJURY; MALE; MICROARRAY ANALYSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PLEIOTROPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RODENT; STELLATE CELL; WILD TYPE;

ANIMALS; CELLS, CULTURED; DISEASE PROGRESSION; GHRELIN; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; MICE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 77950600619     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23421     Document Type: Article

References (33)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
2. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005;85:495-522.
3. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426-457.
4. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988.
5. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159:1029-1037.
6. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006;130:1707-1720.
7. Granata R, Settanni F, Trovato L, Destefanis S, Gallo D, Martinetti M, et al. Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells. J Endocrinol Invest 2006;29: RC19-RC22.
8. Li L, Zhang LK, Pang YZ, Pan CS, Qi YF, Chen L, et al. Cardioprotective effectsof ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin 2006;27:527-535.
9. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:2832-2836.
10. Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005;16:2111-2118.
11. Binn M, Albert C, Gougeon A, Maerki H, Coulie B, Lemoyne M, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 2006;27:1603-1606.
12. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004;110:3674-3679.
13. Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128:1187-1193.
14. Ramalho LN, Ramalho FS, Zucoloto S, Castro-e-Silva Junior, Correa FM, Elias JJ, et al. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis. Hepatogastroenterology 2002;49:1499-1502.
15. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004;101:8227-8232.
16. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, et al. Characterization of time-related changes after experimental bile duct liga-tion. Br J Surg 2008;95:646-656.
17. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007;132:687-697.
18. Chen J, Liu X, Shu Q, Li S, Luo F. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Med Sci Monit 2008;14: BR141-BR146.
19. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardio-vasc Pharmacol 2004;43:165-170.
20. Iseri SO, Sener G, Saglam B, Ercan F, Gedik N, Yegen BC. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept 2008;146:73-79.
21. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, et al. Acylated and unacylated ghrelin promote proliferation and inhibit apopto-sis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007;148:512-529.
22. Tacke F, Brabant G, Kruck E, Horn R, Schoffski P, Hecker H, et al. Ghrelin in chronic liver disease. J Hepatol 2003;38:447-454.
23. Gualillo O, Caminos JE, Kojima M, Kangawa K, Arvat E, Ghigo E, et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 2001;144:687-690.
24. Prodam F, Bellone S, Grugni G, Crino A, Ragusa L, Franzese A, et al. Influence of age, gender, and glucose tolerance on fasting and fed acylated ghrelin in Prader Willi syndrome. Clin Nutr 2009;28:94-99.
25. Kuzuya M, Ando F, Iguchi A, Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes (Lond) 2006;30:1609-1614.
26. Ukkola O, Ravussin E, Jacobson P, Perusse L, Rankinen T, Tschop M, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002;10:782-791.
27. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res 2007;37:239-247.
28. Konturek PC, Brzozowski T, Pajdo R, Nikiforuk A, Kwiecien S, Harsch I, et al. Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004;55:325-336.
29. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007;148:148-159.
30. El EE, Al TA, Hagar H, Arafa M. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 2007;22:1791-1799.
31. Obay BD, Tasdemir E, Tumer C, Bilgin HM, AtmacaM. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides 2008;29:448-455.
32. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008;105:6320-6325.
33. Rudolph J, Esler WP, O'Connor S, Coish PD, Wickens PL, Brands M, et al. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J Med Chem 2007;50: 5202-5216.